VOL. 2, ISSUE 4 | SEPTEMBER 2023
XiFin Launches New Lab Volume Index (LVI) with New Features to Spot Trends
XiFin recently relaunched the Lab Volume Index (LVI) with several new features. The LVI is based on claims data that is run through XiFin RPM. It is a measure of laboratory testing volumes across the nation compared to a baseline average, which the user can now select. Users can now choose a baseline year (2019, 2020, 2021, or 2022) to adjust the LVI visualizations. The LVI distinguishes COVID from routine (i.e., non-COVID) testing volumes over time and lets users select data for specific testing categories, including clinical, pathology, molecular and genomic, immunology and microbiology. Segmentation is based on the type of testing, not the type of laboratory performing the tests. For example, suppose a user selects the molecular
and genetic testing segment. In that case, the resulting chart shows the testing volume of all molecular and genetic testing, irrespective of whether it was performed at a hospital lab, a clinical lab, a pain management clinical or toxicology lab, or a lab specializing in molecular testing. The new LVI is updated monthly. During COVID, some surges and lulls made a weekly measurement relevant. Post-public health emergency (PHE) monthly measurement makes it easier to spot longer-term trends as the monthly data is more stable (i.e., it is less influenced by holidays and temporary disruptions that do not represent a change in volume). One trend that the LVI clearly shows is the growth of molecular testing. While COVID testing (commonly known as PCR testing—a molecular diagnostic) grew and then shrank, molecular testing overall has grown steadily and continues to grow post-COVID. Digging into this data, we found that one of the key drivers of this trend is steady growth in molecular testing related to women’s health.
We encourage you to check out the new LVI and see how your data compares to this national sample of XiFin customer volume.
Updated Screen Lets XiFin RPM Customers Add Non-Medicare Payors to LCD/NCD Coverage Policies
To help ensure that XiFin RPM customers maintain adherence to Medicare coverage limitations, XiFin loads Medicare policy coverage data directly into XiFin RPM and keeps it up to date. The current process uses diagnosis and procedure code ranges to document the policy data. Over the next few months, we are rolling out an updated screen that loads the entire policy, not just the underlying coverage data, including a hyperlink that takes users to the full policy coverage detail, when clicked. XiFin will continue to update any Medicare policy coverage changes. The updated screen makes it easy for XiFin RPM customers to add non-Medicare payors to policies, as appropriate. Customers will be responsible for keeping any private/commercial payor coverage policy data updated if modifications cause the
commercial policy coverage limitations to no longer match the Medicare policy. XiFin customers will be able to easily use logic to make changes to the non-Medicare LCD/NCD coverage policies. This enhancement not only makes it easy to add non-Medicare payors to relevant policies, but it also helps identify non-covered diagnosis codes, so customers can get corrected diagnosis codes from the ordering client, when appropriate. Adding non- Medicare payors to relevant policies makes the billing process more efficient and helps avoid back-end denials. If your Customer Success Manager (CSM) (or Customer Account Manager (CAM) for outsourced billing services customers) has not yet discussed this update screen with you, expect to hear from them about this soon. Your CSM or CAM will schedule a meeting with you and your team to review the new screen.
PAGE 5 | Return to Table of Contents
Made with FlippingBook - Share PDF online